Cargando…

Prostacyclin and thromboxane in benign and malignant breast tumours.

6-keto-PGF1 alpha and thromboxane B2 were determined by radioimmunoassay in 37 extracts of breast carcinomata, 8 fibroadenomata, 12 sclerocystic-disease specimens and 51 normal breast tissues. More prostanoids were extracted from carcinomata than from normal specimens, fibroadenomata or sclerocystic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Laekeman, G. M., Vergote, I. B., Keersmaekers, G. M., Heiremans, J., Haensch, C. F., de Roy, G., Uyttenbroeck, F. L., Herman, A. G.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001625/ https://www.ncbi.nlm.nih.gov/pubmed/3530307

Ejemplares similares

Prostaglandin F2 alpha in benign and malignant breast tumours.
por: Vergote, I. B., et al.
Publicado: (1985)

Platelet sensitivity to prostacyclin in normal subjects, and in patients with benign and malignant tumours of the breast.
por: Benedetto, C., et al.
Publicado: (1985)

Urinary excretion of prostacyclin and thromboxane degradation products in patients with ovarian malignancy: effect of cytostatic treatment.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1989)

Prostacyclin and thromboxane in breast cancer: relationship between steroid receptor status and medroxyprogesterone acetate.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1985)

Prostacyclin, thromboxane and glomerular filtration rate are abnormal in sickle cell pregnancy
por: Obilade, Opeyemi Abayomi, et al.
Publicado: (2017)

Differential effects of oral and transdermal menopausal hormone therapy on prostacyclin and thromboxane in platelets
por: Raz, Limor, et al.
Publicado: (2014)

Survival of mice with NC carcinoma is unchanged by drugs that are thought to inhibit thromboxane synthesis or increase prostacyclin formation.
por: Stamford, I. F., et al.
Publicado: (1986)

Elevated Ratio of Urinary Metabolites of Thromboxane and Prostacyclin Is Associated with Adverse Cardiovascular Events in ADAPT
por: Montine, Thomas J., et al.
Publicado: (2010)

Adherence to the Mediterranean Diet Association with Serum Levels of Nitric Oxide, Prostacyclin, and Thromboxane B(2) among Prinzmetal Angina Patients and Healthy Persons
por: Mohajeri, Mahsa, et al.
Publicado: (2023)

Effect of interleukin 2 on urinary excretion of degradation products of prostacyclin and thromboxane A2 in patients with ovarian cancer.
por: Aitokallio-Tallberg, A., et al.
Publicado: (1995)

Comparative effects of immediate‐release and extended‐release aspirin on basal and bradykinin‐stimulated excretion of thromboxane and prostacyclin metabolites
por: Gamboa, Jorge L., et al.
Publicado: (2016)

Role of E-type prostaglandin receptor EP3 in the vasoconstrictor activity evoked by prostacyclin in thromboxane-prostanoid receptor deficient mice
por: Li, Zhenhua, et al.
Publicado: (2017)

A strategy using NMR peptide structures of thromboxane A2 receptor as templates to construct ligand-recognition pocket of prostacyclin receptor
por: Ruan, Cheng-Huai, et al.
Publicado: (2005)

Expression of thromboxane synthase, TBXAS1 and the thromboxane A2 receptor, TBXA2R, in human breast cancer
por: Watkins, Gareth, et al.
Publicado: (2005)

Differential expression of translation-associated genes in benign and malignant human breast tumours.
por: Adams, S. M., et al.
Publicado: (1992)

Thromboxane Modulates Endothelial Permeability
por: Klausner, J. M., et al.
Publicado: (1994)

Ablative techniques for the treatment of benign and malignant breast tumours
por: Peek, Mirjam C. L., et al.
Publicado: (2017)

Localisation of somatostatin and somatostatin receptors in benign and malignant ovarian tumours
por: Hall, G H, et al.
Publicado: (2002)

In vivo uptake of labelled oestradiol by benign and malignant tumours of the human breast.
por: O'Higgins, N. J., et al.
Publicado: (1973)

Glutathione localisation in benign and malignant human breast lesions.
por: Murray, G. I., et al.
Publicado: (1987)

Multiexponential T2 relaxometry of benign and malignant adipocytic tumours
por: Nikiforaki, Katerina, et al.
Publicado: (2020)

Use of prostacyclin in pulmonary hypertension
por: Vicente, R, et al.
Publicado: (1998)

Malignant Solitary Fibrous Tumour of the Breast Mimicking a Benign Tumor
por: Barco, Israel, et al.
Publicado: (2019)

Differential regulation of RhoA-mediated signaling by the TPα and TPβ isoforms of the human thromboxane A2 receptor: Independent modulation of TPα signaling by prostacyclin and nitric oxide
por: Wikström, Katarina, et al.
Publicado: (2008)

PROSTACYCLIN IN HEALTH AND DISEASE
Publicado: (1983)

Prostacyclin: An Inflammatory Paradox
por: Stitham, Jeremiah, et al.
Publicado: (2011)

Thyroid function in patients with benign and malignant breast disease.
por: MacFarlane, I. A., et al.
Publicado: (1980)

Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy.
por: van der Zee, A. G., et al.
Publicado: (1992)

Inhibiting breast cancer by targeting the thromboxane A(2) pathway
por: Li, Haitao, et al.
Publicado: (2017)

Prostacyclin Synthesis and Prostacyclin Receptor Expression in the Porcine Myometrium: Prostacyclin Potential to Regulate Fatty Acid Transporters, Cytokines and Contractility-Related Factors
por: Blitek, Agnieszka, et al.
Publicado: (2022)

Role of prostacyclin in pulmonary hypertension
por: Mitchell, Jane A., et al.
Publicado: (2014)

Activity of type IV collagenases in benign and malignant breast disease.
por: Davies, B., et al.
Publicado: (1993)

Stability of thromboxane in blood samples
por: Helgadóttir, Helga, et al.
Publicado: (2019)

Distinguishing benign from malignant liver tumours
por: Heiken, Jay P.
Publicado: (2007)

Thromboxane Mobilizes Insect Blood Cells to Infection Foci
por: Roy, Miltan Chandra, et al.
Publicado: (2021)

Prostacyclin Regulation of Allergic Inflammation
por: Patel, Kunj, et al.
Publicado: (2022)

Divergent roles of prostacyclin and PGE(2) in human tendinopathy
por: Bergqvist, Filip, et al.
Publicado: (2019)

Testosterone-to-estradiol ratio and platelet thromboxane release in ischemic heart disease: the EVA project
por: Raparelli, V., et al.
Publicado: (2022)

Identification of mRNAs differentially-expressed between benign and malignant breast tumour cells
por: Liu, D, et al.
Publicado: (2002)

Glutathione S-transferase expression in benign and malignant ovarian tumours.
por: Green, J. A., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_d9vv10vhrlcq0c2im6q69ml03t